Page last updated: 2024-09-03

iguratimod and Leukemia, Acute Monocytic

iguratimod has been researched along with Leukemia, Acute Monocytic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aikawa, Y; Morimoto, K; Tanaka, K; Yamamoto, M; Yamamoto, T1

Other Studies

1 other study(ies) available for iguratimod and Leukemia, Acute Monocytic

ArticleYear
An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2002, Volume: 51, Issue:4

    Topics: Antirheumatic Agents; Benzopyrans; Biotransformation; Blotting, Western; Cell Nucleus; Cytokines; Electrophoresis; Enzyme-Linked Immunosorbent Assay; Humans; I-kappa B Proteins; Interleukin-6; Interleukin-8; Leukemia, Monocytic, Acute; Lipopolysaccharides; NF-kappa B; NF-KappaB Inhibitor alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2002